Technology | Breast Density | January 31, 2019

Volpara Solutions Launches Next-Generation VolparaDensity Software to Support SmartCurve Paddles

Recent FDA clearance enhances breast density assessment performance and expands types of information provided to clinicians

 Volpara Solutions Launches Next-Generation VolparaDensity Software to Support SmartCurve Paddles

January 31, 2019 — Volpara Solutions Inc. received U.S. Food and Drug Administration (FDA) 510(k) clearance for new technologies used in the Volpara Density clinical application for breast density assessment. The updated version of VolparaDensity more accurately reflects breast density from images captured using the Hologic SmartCurve system.

This VolparaDensity update also supports additional breast imaging systems, such as the Siemens Mammomat Fusion and Mammomat Revelation® systems.

As one of the clinical applications within Volpara Enterprise software, VolparaDensity provides radiologists with automated, objective volumetric breast density assessments and a breast density category shown to correlate to the Breast Imaging-Reporting and Data System (BI-RADS) 4th and 5th Editions. It is CE-marked and cleared by the FDA, Health Canada and the TGA.

Women with dense breasts not only have an increased risk of breast cancer but are also impacted by lower mammographic sensitivity that dramatically reduces the chances of early detection. Several large studies have confirmed that as density increases the accuracy of mammography decreases. Thus, women with dense breasts are candidates for additional screening with either ultrasound or magnetic resonance imaging (MRI) depending on their breast density and risk profile.

For more information: www.volparasolutions.com

Related Content

The Food and Drug Administration (FDA) has cleared the new Somatom X.cite premium single-source computed tomography (CT) scanner from Siemens Healthineers together with the new myExam Companion intelligent user interface concept
News | Computed Tomography (CT) | November 21, 2019
November 21, 2019 — The Food and Drug Administration (FDA) has cleared the new Somatom X.cite premium single-source
The RX1270 is Eizo’s highest resolution monitor at 12-megapixels (horizontal 4,200 x vertical 2,800 pixels)
News | Flat Panel Displays | November 21, 2019
November 21, 2019 — Eizo Inc.
Infinitt PACS 7.0 is a faster, more powerful viewer that was built from the ground up to support AI for image analysis and for operational/ workflow improvements in radiology
News | PACS | November 19, 2019
November 19, 2019 — Infinitt North America will be highlighting a next generation,...
 LifeImage Baystate
News | Artificial Intelligence | November 18, 2019
November 18, 2019 — Baystate Health, the premier integrated health syst
News | Artificial Intelligence | November 18, 2019
November 18, 2019 — Visage Imaging, Inc. (Visage), a wholly owned subsidi
RamSoft has been a proponent of the cloud since over a decade; the reason – patient data protection
News | Information Technology | November 18, 2019
November 18, 2019 — A recent report by security firm Emsisoft stated that